News
Videos
Conferences
Events
Resources
Subscribe

David O'Malley, M.D.

Articles by David O'Malley, M.D.

Exploring Another Biomarker in Ovarian Cancer

ByDavid O'Malley, M.D.

June 26th 2018

Folate receptor alpha was a promising biomarker when it came to treatment with mirvetuximab soravtansine.

Latest Updated Articles

Exploring Another Biomarker in Ovarian Cancer
Published: June 26th 2018 | Updated:

Trending on CURE

FDA Approves Darzalex Faspro in High-Risk Smoldering Multiple Myeloma

Amtagvi Prompts Responses in Non–Small Cell Lung Cancer

New Book Spotlights Cancer in Early Adulthood

Sharing More Than 25 Years of Brain Tumor Survival

October Treatment Advances and Survivorship Perspectives in GU Cancers

© 2025 MJH Life Sciences^®

All rights reserved.